Concourse Financial Group Securities, Inc. Aurinia Pharmaceuticals Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$5.32 - $7.33 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$4.81 - $5.78 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$4.93 - $9.31 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$7.13 - $9.49 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$7.77 - $12.27 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$7.77 - $12.27 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$8.96 - $11.69 $0 - $0
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$4.11 - $8.14 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$6.66 - $12.39 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$8.95 - $12.8 $0 - $0
Q1 2022 May 09, 2022	BUY	$10.05 - $22.48 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$17.78 - $33.08 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$10.93 - $23.55 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $0 - $0
Q1 2021 May 13, 2021	BUY	$12.3 - $18.73 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$12.94 - $16.05 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$13.19 - $16.66 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $0 - $0
Q1 2020 May 13, 2020	BUY	$11.34 - $21.46 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$5.34 - $6.59 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$6.05 - $6.75 $0 - $0
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$5.08 - $6.83 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$5.27 - $6.64 $0 - $0

Others Institutions Holding AUPH

# of Institutions

208

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

Black Rock Inc. New York, NY

9.27M
Shares

$82.1 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

8.2M
Shares

$72.6 Million
1.0% of portfolio
Tang Capital Management LLC San Diego, CA

7.23M
Shares

$64 Million
4.52% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$35.1 Million
2.22% of portfolio
State Street Corp Boston, MA

2.95M
Shares

$26.1 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.26B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account